ALPS Medical Breakthroughs ETF
SBIO
SBIO
42 hedge funds and large institutions have $45.1M invested in ALPS Medical Breakthroughs ETF in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
24% more funds holding
Funds holding: 34 → 42 (+8)
8.25% more ownership
Funds ownership: 17.33% → 25.58% (+8.3%)
Holders
42
Holding in Top 10
–
Calls
$1.36M
Puts
$644K
Top Buyers
| 1 | +$4.39M | |
| 2 | +$3.69M | |
| 3 | +$3.53M | |
| 4 |
Morgan Stanley
New York
|
+$1.66M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.4M |
Top Sellers
| 1 | -$396K | |
| 2 | -$147K | |
| 3 | -$32.8K | |
| 4 |
CA
Calton & Associates
Tampa,
Florida
|
-$20K |
| 5 |
Citigroup
New York
|
-$13.8K |